Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Solid tumors are composed of malignant cells surrounded by a tumor-conditioned stroma that contains extracellular matrix and a variety of nonmalignant populations, including myeloid cells, lymphocytes, fibroblasts, and endothelial cells. These stromal elements form a local immunoregulatory network that must be overcome to achieve eradication of established tumors by immunotherapy. On March 21-22, 2012, a symposium was held in Pamplona, Spain, to share the recent advances regarding the molecules and cells that create and sustain this immune-hostile tumor microenvironment. Excellent targets for immunotherapeutic intervention were identified, and a number of therapeutic strategies under translation from mouse to human were presented.

Original publication

DOI

10.1158/0008-5472.can-12-1952

Type

Journal article

Journal

Cancer research

Publication Date

10/2012

Volume

72

Pages

5159 - 5164

Addresses

Division of Hepatology and Gene Therapy, Center for Applied Medical Research, University of Navarra Clinic, University of Navarra, Pamplona, Navarra, Spain.

Keywords

Animals, Humans, Mice, Neoplasms, Immunotherapy, Tumor Microenvironment